Jonathan A. Sugam

1.2k total citations
16 papers, 755 citations indexed

About

Jonathan A. Sugam is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Jonathan A. Sugam has authored 16 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 6 papers in Cognitive Neuroscience. Recurrent topics in Jonathan A. Sugam's work include Neurotransmitter Receptor Influence on Behavior (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Receptor Mechanisms and Signaling (5 papers). Jonathan A. Sugam is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Receptor Mechanisms and Signaling (5 papers). Jonathan A. Sugam collaborates with scholars based in United States and Sweden. Jonathan A. Sugam's co-authors include Regina M. Carelli, Thomas L. Kash, Michael P. Saddoris, Daniel W. Bloodgood, Andrew Holmes, Jeremy J. Day, R. Mark Wightman, Emily G. Lowery‐Gionta, Kristen E. Pleil and Zoé A. McElligott and has published in prestigious journals such as Journal of Neuroscience, Scientific Reports and Biological Psychiatry.

In The Last Decade

Jonathan A. Sugam

16 papers receiving 748 citations

Peers

Countries citing papers authored by Jonathan A. Sugam

Since Specialization

Citations

This map shows the geographic impact of Jonathan A. Sugam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan A. Sugam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan A. Sugam more than expected).

Fields of papers citing papers by Jonathan A. Sugam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan A. Sugam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan A. Sugam. The network helps show where Jonathan A. Sugam may publish in the future.

Co-authorship network of co-authors of Jonathan A. Sugam

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan A. Sugam. A scholar is included among the top collaborators of Jonathan A. Sugam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan A. Sugam. Jonathan A. Sugam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	PBPK-PD modeling for the preclinical development and clinical translation of tau antibodies for Alzheimer’s disease 2022 ·Frontiers in Pharmacology ·(unknown), (unknown), Jonathan A. Sugam, Steve Grauer, (unknown), S. V. Antonenko, Michael Judo, (unknown), Ka Lai Yee	13
2	Serotonin modulates an inhibitory input to the central amygdala from the ventral periaqueductal gray 2022 ·Neuropsychopharmacology ·Olivia J. Hon, Jeffrey F. DiBerto, Christopher M. Mazzone, Jonathan A. Sugam, Daniel W. Bloodgood, J. Andrew Hardaway, (unknown), (unknown), Nora M. McCall, Alberto J. López, Thomas L. Kash, Emily G. Lowery‐Gionta	16
3	Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology 2021 ·Neurobiology of Disease ·Yuan Tian, Yi Wang, (unknown), Yinghui Hu, Jonathan A. Sugam, Markus Koglin, Shawn J. Stachel, Heather Zhou, Jason M. Uslaner, Sophie Parmentier‐Batteur	13
4	Astrocytic expression of the Alzheimer’s disease risk allele, ApoEε4, potentiates neuronal tau pathology in multiple preclinical models 2021 ·Scientific Reports ·(unknown), (unknown), Marija Usenovic, Heather Zhou, Jonathan A. Sugam, Sophie Parmentier‐Batteur, Bhavya Voleti	24
5	Mesolimbic Dopamine Dynamically Tracks, and Is Causally Linked to, Discrete Aspects of Value-Based Decision Making 2020 ·UNC Libraries ·Jonathan A. Sugam, Karl Deisseroth, Michael P. Saddoris, Ilana B. Witten, Garret D. Stuber, Regina M. Carelli	1
6	Mu Opioid Receptor Modulation of Dopamine Neurons in the Periaqueductal Gray/Dorsal Raphe: A Role in Regulation of Pain 2020 ·UNC Libraries ·Zoé A. McElligott, Alberto J. López, Nora M. McCall, Jessica M. McKlveen, Thomas L. Kash, Emily G. Lowery‐Gionta, Kristen E. Pleil, Chia Li, Jonathan A. Sugam	2
7	Fear extinction requires infralimbic cortex projections to the basolateral amygdala 2018 ·Translational Psychiatry ·Daniel W. Bloodgood, Jonathan A. Sugam, Andrew Holmes, Thomas L. Kash	164
8	Cocaine Self-Administration Experience Induces Pathological Phasic Accumbens Dopamine Signals and Abnormal Incentive Behaviors in Drug-Abstinent Rats 2016 ·Journal of Neuroscience ·Michael P. Saddoris, (unknown), Jonathan A. Sugam, Regina M. Carelli	44
9	Prior Cocaine Experience Impairs Normal Phasic Dopamine Signals of Reward Value in Accumbens Shell 2016 ·Neuropsychopharmacology ·Michael P. Saddoris, Jonathan A. Sugam, Regina M. Carelli	18
10	Mu Opioid Receptor Modulation of Dopamine Neurons in the Periaqueductal Gray/Dorsal Raphe: A Role in Regulation of Pain 2016 ·Neuropsychopharmacology ·Chia Li, Jonathan A. Sugam, Emily G. Lowery‐Gionta, Zoé A. McElligott, Nora M. McCall, Alberto J. López, Jessica M. McKlveen, Kristen E. Pleil, Thomas L. Kash	120
11	Nociceptin receptor antagonist SB 612111 decreases high fat diet binge eating 2016 ·Behavioural Brain Research ·J. Andrew Hardaway, (unknown), (unknown), Christopher M. Mazzone, Jonathan A. Sugam, Jeffrey F. DiBerto, Emily G. Lowery‐Gionta, Lara S. Hwa, Kristen E. Pleil, Cynthia M. Bulik, Thomas L. Kash	27
12	Neuropeptide Regulation of Signaling and Behavior in the BNST 2014 ·Molecules and Cells ·Thomas L. Kash, Kristen E. Pleil, Catherine A. Marcinkiewcz, Emily G. Lowery‐Gionta, Nicole A. Crowley, Christopher M. Mazzone, Jonathan A. Sugam, J. Andrew Hardaway, Zoé A. McElligott	82
13	Mesolimbic Dopamine Dynamically Tracks, and Is Causally Linked to, Discrete Aspects of Value-Based Decision Making 2014 ·Biological Psychiatry ·Michael P. Saddoris, Jonathan A. Sugam, Garret D. Stuber, Ilana B. Witten, Karl Deisseroth, Regina M. Carelli	82
14	Nucleus Accumbens Neurons Track Behavioral Preferences and Reward Outcomes During Risky Decision Making 2013 ·Biological Psychiatry ·Jonathan A. Sugam, Michael P. Saddoris, Regina M. Carelli	38
15	Rolling the Dice: The Importance of Mesolimbic Dopamine Signaling in Risky Decision Making 2012 ·Neuropsychopharmacology ·Jonathan A. Sugam, Regina M. Carelli	6
16	Phasic Nucleus Accumbens Dopamine Encodes Risk-Based Decision-Making Behavior 2011 ·Biological Psychiatry ·Jonathan A. Sugam, Jeremy J. Day, R. Mark Wightman, Regina M. Carelli	105

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact